Skip to content

A Randomised Controlled Trial to Investigate the Effects of a Mindfulness Smartphone App on Well-being in the Workplace

A Randomised Controlled Trial to Investigate the Effects of the Headspace Mindfulness Smartphone App on Psychological Well-being and Biological Indicators of Stress in the Workplace

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01661569
Enrollment
120
Registered
2012-08-09
Start date
2012-08-31
Completion date
2013-01-31
Last updated
2012-08-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Well-being, Work Stress

Keywords

Mindfulness, meditation, stress, well-being, work stress, blood pressure, cortisol

Brief summary

We propose a randomised controlled trial in a workplace setting to investigate whether a smartphone-delivered programme of mindfulness meditation influences psychological and biological indicators of well-being. We hypothesise that after 8 weeks participants who complete the meditation programme will show increases in psychological well-being and reduced activation of stress-related biological pathways.

Detailed description

Mindfulness-based therapies can reduce depressive symptoms in patients and healthy subjects. Therapies such as MBSR (mindfulness-based stress reduction) typically consist of 8 group sessions led by an experienced practitioner, plus home practice and one full day of meditation. In this study we aim to investigate whether a mindfulness programme delivered as a series of podcasts on a mobile phone app could lead to gains in well-being and a reduction in stress.

Interventions

OTHERHeadspace On-the-go app

Participants will be given access to a 45-day programme of mindfulness meditation, created and branded by Headspace. They will be encouraged to listen to one meditation podcast each day, or as frequently as possible over 8 weeks.

Sponsors

British Heart Foundation
CollaboratorOTHER
Headspace Meditation Limited
CollaboratorINDUSTRY
Technical University Dresden
CollaboratorUNKNOWN
University College, London
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Employees of a UK high-tech company * Raised levels of work stress (overcommitment\>2) or depression (CESD\>1)

Exclusion criteria

* treated for anxiety, depression or hypertension * taking medication containing steroids

Design outcomes

Primary

MeasureTime frameDescription
Well-being8 weeksPsychological well-being will be assessed using the Warwick Edinburgh Mental Well-Being Scale

Secondary

MeasureTime frameDescription
Blood pressure8 weeksBlood pressure over the working day will be measured as an indicator of activation of the stress response

Other

MeasureTime frameDescription
Psychological stress8 weeksStress will be measured using the Perceived Stress Scale and measures of job strain, based on Karasek (where job strain is a combination of high demands and low control).
Cortisol8 weeksHair cortisol concentration, as an indicator of activation of the HPA axis

Countries

United Kingdom

Contacts

Primary ContactSophie K Bostock, BMedSci, MSc
sophie.bostock.09@ucl.ac.uk+44 (0)7779578733

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026